(b)(4) a review of the device history records, indicated that the patch was processed and inspected according to procedures and was therefore released following acceptable quality inspections and tests, and no anomaly was found.(b)(4) a visual inspection of the returned patch was performed by the quality assurance supervisor.The product was returned in a biohazard package.The inspection revealed a collagen excess.Therefore, the product does not conform to its specification.(b)(4) the inspection confirms that the product does not conform to its specification.Therefore, a non-conformity report has been initiated in order to investigate the root cause and take appropriate corrective actions if necessary.
|